Advances in sleep disorders;Avances en el estudio de los trastornos del sueño

Revista de Neurologia

Volumn 40, Issue 8, 2005, Pages 485-491

  Peraita Adrados, Rosa ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Circadian rhythm disorders; Diagnosis; Hipersomnia; Insomnia; Parasomnia; Treatment

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT;

APNEA; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL FEATURE; DREAM; HUMAN; HYPERSOMNIA; INSOMNIA; INTERNATIONAL CLASSIFICATION OF DISEASES; KNOWLEDGE; MEDICAL SPECIALIST; MEDICINE; METHODOLOGY; MORBIDITY; NIGHT; PARASOMNIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSICIAN; POLYSOMNOGRAPHY; POPULATION; PREVALENCE; REVIEW; SLEEP; SLEEP DISORDER; SNORING; SOCIAL LIFE; SOCIAL WORK; TRAFFIC ACCIDENT; VIDEO POLYSOMNOGRAPHY; WAKEFULNESS; WORKPLACE; CIRCADIAN RHYTHM; CLASSIFICATION; PHYSIOLOGY; SLEEP APNEA SYNDROME;

CIRCADIAN RHYTHM; HUMANS; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; SLEEP DISORDERS; WAKEFULNESS;

EID: 24644490173     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4008.2004455     Document Type: Review

References (40)

1. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages in human subjects. Public Health Service Publication No 204. Washington, DC: US Government Printing Office; 1968.
2. Besset A. Polysomnography. In Billiard M, ed. Sleep. Physiology, investigations and medicine. New York: Kluwer Academic/Plenum Publishers; 2003. p. 127-38.
3. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness. Sleep 1986; 9: 519-24.
4. ICSD: The international classification of sleep disorders: diagnostic and coding manual. Diagnostic Classification Steering Committee. In MJ Thorpy Chairman, ed. Rochester, Minnesota: American Sleep Disorders Association; 1990.
5. Peraita-Adrados R. Transient and short insomnia. In Billiard M, ed. Sleep. Physiology, investigations and medicine. New York: Kluwer Academic/Plenum Publishers; 2003. p. 201-5.
6. Peraita-Adrados R, Ezpeleta-Echávarri D. Tratamiento del insomnio. Rev Clin Esp 1999; 2: 109-13.
7. Vela-Bueno A. Insomnia. In Rakel RE, ed. Conn's current therapy. Philadelphia: WB Saunders; 1992. p. 28-32.
8. Kales JD, Kales A. Evaluation and treatment of insomnia. Psychiatry Annals 1987; 17: 459-64.
9. Vaughn-McCall W, Edinger JD. Subjective total insomnia: an example of sleep state misperception. Sleep 1992; 15: 71-3.
10. Navelet Y. El insomnio del niño, aspectos clínicos y tratamiento. In Peraita-Adrados MR, ed. Trastornos del sueño en la infancia. Madrid: CEPE; 1992. p. 107-20.
11. Montplaisir J, Godbout R, Pelletier G, Bédard MA. Restless legs syndrome and periodic limb movements during sleep. In Kryger MH, Roth-Dement WC, eds. Principles and practice of sleep medicine. 2 ed. New York: WB Saunders; 1993. p. 589-98.
12. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In Guilleminault C, ed. Sleeping and walking disorders (indications and techniques). Menlo Park, CA: Addison-Wesley; 1982. p. 265-95.
13. Gelineau J. De la narcolepsie. Gazette des Hôpitaux (Paris) 1880; 53: 626-8.
14. Dement WC, Carskadon M, Ley R. The prevalence of narcolepsy II [abstract]. Sleep Res 1973; 2: 147.
15. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypotalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998; 95: 322-7.
16. Sakurai T, Ameniya A, Ishii M, Matzuzaki I, Chemelli RM Tanaka H, et al. Orexins and orexins receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour. Cell 1998; 92: 573-85.
17. Westphal C. Eigentümliche mit Einschlafen verbundene Anfälle. Arch Psychiatr Nervenkr 1877; 7: 631-5.
18. Mignot E, Tafti M, Dement WC, Grumet FC. Narcolepsy and immunity. Adv Neuroimmunol 1995; 5: 523-37.
19. Nishino S, Riplay B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy (letter). Lancet 2000; 355: 39-40.
20. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-7.
21. Rechtschaffen A, Dement WC. Narcolepsy and hypersomnia. In Kales A, ed. Sleep: physiology and pathology. New York: JB Lippincott; 1969. p. 119-30.
22. Roth B. Narcolepsy and hypersomnia: review and classification of 642 personnaly observed cases. Schweiz Arch Neurol Neurochir Psychiatr 1976; 119: 31-41.
23. Billiard M. Other hypersomnias. In Thorpy MJ, ed. Handbook of sleep disorders. New York: Marcel Dekker; 1990. p. 353-71.
24. Kleine W. Periodische Schlafsucht. Mschr Psychiatr Neurol 1925; 57: 285-320.
25. Dauvilliers Y, Mayer G, Lecendreaux M, Neidhart E, Peraita-Adrados R, Sonka K, et al. Kleine-Levin syndrome. An autoinmune hypothesis based on clinical and genetic analyses. Neurology 2002; 59: 1739-45.
26. Castilla del Pino C. El síndrome de Levin. Rev Clin Esp 1951; 43: 341-5.
27. Leger D. The cost of sleep-related accidents: a report for the National Commission on Sleep Disorders Research. Sleep 1994; 17: 84-93.
28. Teran-Santos J, Jiménez-Gómez A, Cordero-Guerrero J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1999; 340: 847-51.
29. Burwell C, Robin E, Whaley R. Extreme obesity associate with alveolar hypoventilation: a Pickwickian syndrome. Am J Med 1956; 2: 811-8.
30. Gastaut H, Tassinari CA, Duron B. Etude polygraphique des manifestations épisodiques (hypniques et respiratoires) diurnes et nocturnes du Syndrome de Pickwick. Rev Neurol (Paris) 1965; 112: 573-9.
31. Guilleminault C, Dement WC. Sleep apnea syndromes. New York: Alan R Liss; 1978.
32. Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J, et al. Mortality in sleep apnea: a multivariative analysis of risk factors. Sleep 1995; 18: 149-57.
33. Bassetti C, Aldrich MS, Chervin RD, Quint D. Sleep apnea patients with transient ischemic attack and stroke: a prospective study of 59 patients. Neurology 1996; 47: 1167-73.
34. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnea by continuous positive pressure through the nares. Lancet 1981; 1: 862-5.
35. Fujita S, Conway W, Zorick F, Roth T. Surgical correction of anatomical abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 1981; 89: 923-34.
36. Winkels W, Klutmann M, Bias R, Wessolowski T, Simon H. Effectiveness of an anti-snoring prosthesis in obstructive sleep apnea syndrome. Pneumologie 1997; 3: 802-3.
37. Benoît O. Régulation circadienne des états de veille et de sommeil. In Benoît O, Foret J, eds. Le sommeil humain. Bases expérimentales, physiologiques et physiopathologiques. Paris: Masson; 1979. p. 95-114.
38. Peraita-Adrados R. Diagnóstico diferencial entre parasomnias y epilepsia. Rev Neurol 1998; 26: 479-80.
39. Mahowald MW, Schenck CH. REM sleep behavior disorder. In Thorpy MJ, ed. Handbook of sleep disorders. New York: Marcel Dekker; 1990. p. 567-93.
40. Scheffer IE, Bhatia K, Lopes-Cendes I, Fish DR, Marsden CD, Andermann E, et al. Autosomal dominant frontal epilepsy misdiagnosed as a sleep disorder. Lancet 1994; 343: 515-7.